Transcriptional Regulation of CD43 Gene Expression

Shelley, Carl S.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Type: First Independent Research Support & Transition (FIRST) Awards (R29)
• Project #: 1R29DK050779-01
• Application #: 2151840
• Study Section: Pathology A Study Section (PTHA)
• Project Start: 1996-03-01
• Project End: 2001-02-28
• Budget Start: 1996-03-01
• Budget End: 1997-02-28
• Support Year: 1
• Fiscal Year: 1996

Institution

• Name: Massachusetts General Hospital
• City: Boston
• State: MA
• Country: United States
• Zip Code: 02199

Publications

Shelley, C S; Da Silva, N; Teodoridis, J M (2001) During U937 monocytic differentiation repression of the CD43 gene promoter is mediated by the single-stranded DNA binding protein Pur alpha. Br J Haematol 115:159-66

Farokhzad, O C; Teodoridis, J M; Park, H et al. (2000) CD43 gene expression is mediated by a nuclear factor which binds pyrimidine-rich single-stranded DNA. Nucleic Acids Res 28:2256-67

Farokhzad, O C; Shelley, C S; Arnaout, M A (1996) Induction of the CD11b gene during activation of the monocytic cell line U937 requires a novel nuclear factor MS-2. J Immunol 157:5597-605